Collectively, these data clearly suggested that CCL2 played a carcinogenic role by regulating miRNA-128/PARP2 signal pathway, indicating that targeting CCL2/miRNA-128/PARP2 may be a new effective strategy for gastric cancer therapy. This evidence concerns the gene PARP2 and gastric cancer.